Central Nervous System Infections in Denmark
Danish Study Group of Infections of the Brain: A Nationwide Prospective Observational Cohort Study of All Central Nervous System Infections in Adults at Departments of Infectious Diseases in Denmark
Aalborg University Hospital
1,900 participants
Jan 1, 2015
OBSERVATIONAL
Conditions
Summary
The Danish Study Group of Infections of the Brain is a collaboration between all departments of infectious diseases in Denmark. The investigators aim to monitor epidemiological trends in central nervous system (CNS) infections by a prospective registration of clinical characteristics and outcome of all adult (\>17 years of age) patients with community-acquired CNS infections diagnosed and/or treated at departments of infectious diseases in Denmark since 1st of January 2015.
Eligibility
Inclusion Criteria33
- Definitions of central nervous system infections:
- For all cases with unproven aetiologies no alternative diagnosis than CNS infection is thought more likely after completed multidisciplinary diagnostic work-up.
- \- All patients have to have a clinical presentation consistent with non-bacterial meningitis (e.g. headache, neck stiffness, photo- or phonophobia, fever)
- and
- Cerebrospinal fluid leukocytes\>10 cells/ml
- Patients with viral meningitis with undetermined pathogen have to have:
- CSF leukocytes\> 10/mL and no other more probable diagnosis assessed by the local investigator.
- In case of doubt, patients are discussed with the DASGIB secretary and chair or at meetings.
- and
- Proven bacterial aetiology (CSF or blood culture/DNA based technology or antigen tests)
- Patients with bacterial meningitis in whom the bacteria cannot not be cultured or identified by DNA-based technologies have to have:
- \- CSF leukocytes\> 10/mL and no other more probable diagnosis assessed by the local investigator.
- In case of doubt, patients are discussed with the DASGIB secretary and chair or at meetings.
- \- All patient have a clinical presentation consistent with brain abscess (e.g. headache, focal neurological deficit, mass lesion on cranial imaging)
- and
- \- Proven microbiological aetiology by culture/DNA-based technology from pus from brain abscess or blood or CSF
- or
- \- Aspiration of pus from the brain abscess
- or
- \- Response to antimicrobial treatment
- or
- \- Tumour ruled out
- or
- \- Tumour thought less probable than abscess on MRI using diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) sequences.
- \- A clinical presentation consistent with neuroborreliosis (e.g. radiculopathy)
- and
- \- CSF pleocytosis\>10 leukocytes/mL
- and
- \- Positive intrathecal B.burgdorferi antibody production index.
- and either
- \- Positive syphilis serology in serum combined with CSF leukocytes\>10/mL
- or
- \- CSF syphilis antibodies.
Exclusion Criteria1
- \- We exclude cases of proven or suspected autoimmune encephalitis.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prospective observational registration of clinical characteristics and outcome
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03418441